Enhanced Care for Smoking Cessation
Trial Summary
What is the purpose of this trial?
The modest goal of this study is to replicate the behavioral outcomes of the opt out MUSC-Tobacco Treatment Program in the following three patient groups: 1) psychiatric inpatients housed in the Institute of Psychiatry (IOP) in Charleston; 2) non-IOP patients seen in Charleston; and 3) patients seen in the other four MUSC affiliated hospitals combined (i.e., Chester, Florence, Lancaster, and Marion). The aims and the design/methods utilized for evaluation will be the same for each of the three patient groups.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the Enhanced Care treatment for smoking cessation?
Research shows that enhanced care, which includes additional support and resources, can improve smoking cessation outcomes. For example, a study found that more patients in an enhanced care program were asked about their smoking status and advised to quit compared to usual care, leading to better engagement in quitting efforts.12345
Is the Enhanced Care for Smoking Cessation treatment safe for humans?
The studies reviewed focus on the feasibility and effectiveness of smoking cessation treatments, but they do not provide specific safety data for Enhanced Care or similar treatments. However, the use of FDA-approved smoking cessation medications in these studies suggests a level of safety, as these medications have been evaluated for human use.678910
How does the Enhanced Care treatment for smoking cessation differ from other treatments?
Enhanced Care for smoking cessation may involve more intensive behavioral support compared to basic care, potentially delivered by primary care nurses or auxiliary healthcare workers. This approach could offer a more structured and frequent support system, which might be more effective than standard minimal interventions or pharmacological treatments like nicotine replacement therapy.35111213
Research Team
Kenneth M Cummings, PhD
Principal Investigator
Medical University of South Carolina
Eligibility Criteria
This trial is for hospitalized cigarette smokers over the age of 18 who are being discharged back to their homes. Participants must have a phone number and be able to communicate in English. It's not open to those without a phone or who can't speak English.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the opt-out MUSC-Tobacco Treatment Program during hospitalization
Follow-up
Participants are monitored for smoking behavior and use of cessation medication after discharge
Treatment Details
Interventions
- Basic Care
- Enhanced Care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Medical University of South Carolina
Lead Sponsor